PATENT CLAIM ANALYSIS

Application Number: 15983269
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "326000"]

Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.

Claim (Index 8):
A method of treating Alzheimer's disease in a patient, comprising administering to a patient in need of such treatment an effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15874947', '13501587', '13883788', '13296384', '15520462']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.764537794783465
- 35 USC 102 Novelty (BERT): 0.5235292804051445
- Combined Prediction Score: 0.7404369433456328
- Mean Citation Score: 279.766168
- Max Citation Score: 340.1373
- Similarity Product: 296.7075546087205

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test